Transcriptomics Market size was valued at USD 5.57 Bn. in 2023 and the total Transcriptomics revenue is expected to grow by 13.56 % from 2024 to 2030, reaching nearly USD 13.57 Bn.Transcriptomics Market Overview:
Transcriptomics is the study and collection of transcriptomes, and it has a wide range of applications, most notably in molecular genetics. There could be a lot of new product launches in the global transcriptomics industry.Transcriptomics Market Dynamics:
The growing demand for personalized medicine is the major driving factor for market growth. In the biotechnology business, there is an increase in the number of PCR applications; this aspect is projected to fuel market growth. The transcriptomics market is predicted to develop due to improvements in the field of transcriptomics, such as the widespread usage of RNA-sequencing and the rise in applications of transcriptomics, such as drug discovery. Furthermore, increased financing and grants from various commercial and government entities have boosted industry growth. NanoString Technologies, Inc. announced new technologies to evaluate the immune response in COVID-19 disease research in June 2020. To provide a thorough investigation of the viral infection and immune response, the business created the nCounter Host Response Gene Expression Panel and the COVID-19 Panel Plus spike-in. MI Transcriptome, Caris Life Sciences' newest addition to its complete genomic profiling solution, was launched in February 2020, allowing Whole Transcriptome Sequencing (WTS). NuGEN Technologies, Inc.'s Trio RNA-Seq, for example, is well suited for low abundance transcript applications since it provides a very sensitive whole Transcriptomics solution. However, several RNA sequencing limitations and a scarcity of experienced personnel are projected to limit industry growth. Due to a lack of understanding of concepts and the selection of precise techniques, research and development costs may rise. This can also lengthen the time it takes to complete some studies. The report has profiled twenty-one key players in the market from different regions. However, the report has considered all market leaders, followers and new entrants with investors while analyzing the market and estimation the size of the same. Increasing R&D activities in each region are different and focus is given on the regional impact on the cost, availability of advanced technology are analyzed and report has come up with recommendations for a future hot spot in APAC region.To know about the Research Methodology :- Request Free Sample Report
Transcriptomics Market Segment Analysis:
The Global Transcriptomics Market is segmented on the basis of Technology and Application. Based on Application, the Diagnostics and Disease Profiling segment is expected to hold a dominant market share during the forecast period. In diagnostics and illness analysis, transcriptomics has a wide range of applications. Transcriptome analyses have been widely used to better understand tumour heterogeneity, classify cancers into molecular subtypes, and identify signals that predict treatment response and patient outcomes. Transcriptomics has transitioned in recent years from pure research uses to diagnostics and medical applications. Transcriptomics are important techniques for speeding up disease diagnosis. The global burden of chronic diseases such as cancer and diabetes is continuously increasing, necessitating the development of improved illness and diagnostic technologies. According to a report issued by GLOBOCAN 2020, there were around 19.2 million new cancer cases and 9.95 million cancer deaths reported globally. This rapidly growing patient base is likely to have a positive impact on segmental growth. Various transcriptomics market companies are always working on creating and introducing new instruments and techniques in the field of illnesses and diagnostics. For example, Ambry Genetics (Ambry) launched the transcriptomic test +RNAinsight in October 2022.Transcriptomics Market Regional Insights:
North America is expected to account for significant market share during the forecast period. North America is predicted to develop the fastest during the forecast period, thanks to increased opportunities, rising healthcare spending, and the implementation of favourable government programmes. North America, particularly the United States, is home to the majority of global manufacturers of transcriptomic systems, platforms, equipment, and technologies. Increased investments in transcriptomics and genomics R&D, as well as increased financing for disease pathology research, have contributed to the company's growth. The growing emphasis on sequencing technologies, the development of more advanced biomedical techniques, and the strong presence of important firms in the region are all likely to boost market revenue growth. The report also helps in understanding the Global Transcriptomics Market dynamics, structure by analyzing the market segments and project the Global Transcriptomics Market size. Clear representation of competitive analysis of key players by product, price, financial position, product portfolio, growth strategies, and regional presence in the Global Transcriptomics Market make the report investor’s guide.Transcriptomics Industry Ecosystem
Transcriptomics Market Scope: Inquire before buying
Global Transcriptomics Market Report Coverage Details Base Year: 2023 Forecast Period: 2024-2030 Historical Data: 2018 to 2023 Market Size in 2023: USD 5.57 Bn. Forecast Period 2024 to 2030 CAGR: 13.56% Market Size in 2030: USD 13.57 Bn. Segments Covered: by Technology Microarray Real-time Quantitative Polymerase Chain Reaction (Q-PCR) Sequencing Technologies Others by Application Consumables Instruments Other Products by Application Diagnostics and Disease Profiling Drug Discovery Other Applications Transcriptomics Market, by Region
North America (United States, Canada and Mexico) Europe (UK, France, Germany, Italy, Spain, Sweden, Austria and Rest of Europe) Asia Pacific (China, South Korea, Japan, India, Australia, Indonesia, Malaysia, Vietnam, Taiwan, Bangladesh, Pakistan and Rest of APAC) Middle East and Africa (South Africa, GCC, Egypt, Nigeria and Rest of ME&A) South America (Brazil, Argentina Rest of South America)Transcriptomics Market Key Players
1. Becton 2. GE Healthcare 3. Roche Diagnostics 4. Agilent Technologies 5. Thermo Fisher Scientific 6. Illumina, Inc. 7. F. Hoffmann-La Roche Ltd 8. Beckman Coulter, Inc 9. BD 10.Biological Industries 11.bioMérieux SA 12.Bio-Rad Laboratories, Inc 13.Cepheid 14.Takara Bio Inc. 15.Cytognomix 16.Edico Genome 17.Siemens AG 18.QIAGEN 19.Merck KGaA 20.Kapa Biosystems 21.Spatial TranscriptomicsFrequently Asked Questions:
1. Which region has the largest share in the Global Transcriptomics Market? Ans: In 2023, North America has the largest market share in the global Transcriptomics market. 2. What is the growth rate of the Global Transcriptomics Market? Ans: The Global Transcriptomics Market is growing at a CAGR of 13.56% during the forecasting period 2024-2030. 3. What is the scope of the Global Transcriptomics market report? Ans: The Global Transcriptomics Market report helps with the PESTEL, PORTER, Recommendations for Investors & Leaders, and market estimation of the forecast period. 4. Who are the key players in the Global Transcriptomics market? Ans: The important key players in the Global Transcriptomics Market are – Becton, GE Healthcare, Roche Diagnostics, Agilent Technologies, Thermo Fisher Scientific, Illumina, Inc., F. Hoffmann-La Roche Ltd, Beckman Coulter, Inc, BD, Biological Industries, bioMérieux SA, Bio-Rad Laboratories, Inc, Cepheid, Takara Bio Inc., Cytognomix, Edico Genome, Siemens AG, QIAGEN, Merck KGaA, Kapa Biosystems, and Spatial Transcriptomics. 5. What is the forecast period of the global transcriptomics market? Ans: The forecasting period of the Global Transcriptomics Market is from 2024 to 2030.
1. Transcriptomics Market Introduction 1.1. Study Assumption and Market Definition 1.2. Scope of the Study 1.3. Executive Summary 2. Global Transcriptomics Market: Competitive Landscape 2.1. MMR Competition Matrix 2.2. Competitive Landscape 2.3. Market share analysis of major players 2.4. Products specific analysis 2.5. Key Players Benchmarking 2.5.1. Company Name 2.5.2. Company Location 2.5.3. Product Segment 2.5.4. End-user Segment 2.5.5. Revenue (2023) 2.5.6. Growth Rate (Y-O-Y in %) 2.5.7. Key Development 2.5.8. Market Share 2.6. Industry Ecosystem Analysis 2.7. Market Structure 2.7.1. Market Leaders 2.7.2. Market Followers 2.7.3. Emerging Players 2.8. Consolidation of the Market 2.8.1. Strategic Initiatives and Developments 2.8.2. Mergers and Acquisitions 2.8.3. Collaborations and Partnerships 2.8.4. Product Launches and Innovations 3. Transcriptomics Market: Dynamics 3.1. Transcriptomics Market Trends 3.2. Transcriptomics Market Dynamics 3.2.1. Drivers 3.2.2. Restraints 3.2.3. Opportunities 3.2.4. Challenges 3.3. PORTER’s Five Forces Analysis 3.3.1. Threat of New Entrants 3.3.2. Threat of Substitutes 3.3.3. Bargaining Power of Suppliers 3.3.4. Bargaining Power of Buyers 3.3.5. Intensity of Competitive Rivalry 3.4. PESTLE Analysis 3.5. Regulatory Landscape 3.5.1. Regulatory Bodies, Government Agencies, and Other Organizations 3.5.2. Regulatory Framework by Region 3.6. Patent Analysis 3.6.1. Jurisdiction and Top Applicants Analysis 4. Transcriptomics Market: Global Market Size and Forecast by Segmentation (by Value in USD Mn) (2023-2030) 4.1. Transcriptomics Market Size and Forecast, by Technology (2023-2030) 4.1.1. Microarray 4.1.2. Real-time Quantitative Polymerase Chain Reaction (Q-PCR) 4.1.3. Sequencing Technologies 4.2. Transcriptomics Market Size and Forecast, by Product (2023-2030) 4.2.1. Consumables 4.2.2. Instruments 4.2.3. Other Products 4.3. Transcriptomics Market Size and Forecast, by Application (2023-2030) 4.3.1. Diagnostics and Disease Profiling 4.3.2. Drug Discovery 4.3.3. Other Applications 4.4. Transcriptomics Market Size and Forecast, by Region (2023-2030) 4.4.1. North America 4.4.2. Europe 4.4.3. Asia Pacific 4.4.4. Middle East and Africa 4.4.5. South America 5. North America Transcriptomics Market Size and Forecast by Segmentation (by Value in USD Mn) (2023-2030) 5.1. North America Transcriptomics Market Size and Forecast, by Technology (2023-2030) 5.1.1. Microarray 5.1.2. Real-time Quantitative Polymerase Chain Reaction (Q-PCR) 5.1.3. Sequencing Technologies 5.2. North America Transcriptomics Market Size and Forecast, by Product (2023-2030) 5.2.1. Consumables 5.2.2. Instruments 5.2.3. Other Products 5.3. North America Transcriptomics Market Size and Forecast, by Application (2023-2030) 5.3.1. Diagnostics and Disease Profiling 5.3.2. Drug Discovery 5.3.3. Other Applications 5.4. North America Transcriptomics Market Size and Forecast, by Country (2023-2030) 5.4.1. United States 5.4.1.1. United States Transcriptomics Market Size and Forecast, by Technology (2023-2030) 5.4.1.1.1. Microarray 5.4.1.1.2. Real-time Quantitative Polymerase Chain Reaction (Q-PCR) 5.4.1.1.3. Sequencing Technologies 5.4.1.2. United States Transcriptomics Market Size and Forecast, by Product (2023-2030) 5.4.1.2.1. Consumables 5.4.1.2.2. Instruments 5.4.1.2.3. Other Products 5.4.1.3. United States Transcriptomics Market Size and Forecast, by Application (2023-2030) 5.4.1.3.1. Diagnostics and Disease Profiling 5.4.1.3.2. Drug Discovery 5.4.1.3.3. Other Applications 5.4.2. Canada 5.4.2.1. Canada Transcriptomics Market Size and Forecast, by Technology (2023-2030) 5.4.2.1.1. Microarray 5.4.2.1.2. Real-time Quantitative Polymerase Chain Reaction (Q-PCR) 5.4.2.1.3. Sequencing Technologies 5.4.2.2. Canada Transcriptomics Market Size and Forecast, by Product (2023-2030) 5.4.2.2.1. Consumables 5.4.2.2.2. Instruments 5.4.2.2.3. Other Products 5.4.2.3. Canada Transcriptomics Market Size and Forecast, by Application (2023-2030) 5.4.2.3.1. Diagnostics and Disease Profiling 5.4.2.3.2. Drug Discovery 5.4.2.3.3. Other Applications 5.4.3. Mexico 5.4.3.1. Mexico Transcriptomics Market Size and Forecast, by Technology (2023-2030) 5.4.3.1.1. Microarray 5.4.3.1.2. Real-time Quantitative Polymerase Chain Reaction (Q-PCR) 5.4.3.1.3. Sequencing Technologies 5.4.3.2. Mexico Transcriptomics Market Size and Forecast, by Product (2023-2030) 5.4.3.2.1. Consumables 5.4.3.2.2. Instruments 5.4.3.2.3. Other Products 5.4.3.3. Mexico Transcriptomics Market Size and Forecast, by Application (2023-2030) 5.4.3.3.1. Diagnostics and Disease Profiling 5.4.3.3.2. Drug Discovery 5.4.3.3.3. Other Applications 6. Europe Transcriptomics Market Size and Forecast by Segmentation (by Value in USD Mn) (2023-2030) 6.1. Europe Transcriptomics Market Size and Forecast, by Technology (2023-2030) 6.2. Europe Transcriptomics Market Size and Forecast, by Product (2023-2030) 6.3. Europe Transcriptomics Market Size and Forecast, by Application (2023-2030) 6.4. Europe Transcriptomics Market Size and Forecast, by Country (2023-2030) 6.4.1. United Kingdom 6.4.1.1. United Kingdom Transcriptomics Market Size and Forecast, by Technology (2023-2030) 6.4.1.2. United Kingdom Transcriptomics Market Size and Forecast, by Product (2023-2030) 6.4.1.3. United Kingdom Transcriptomics Market Size and Forecast, by Application (2023-2030) 6.4.2. France 6.4.2.1. France Transcriptomics Market Size and Forecast, by Technology (2023-2030) 6.4.2.2. France Transcriptomics Market Size and Forecast, by Product (2023-2030) 6.4.2.3. France Transcriptomics Market Size and Forecast, by Application (2023-2030) 6.4.3. Germany 6.4.3.1. Germany Transcriptomics Market Size and Forecast, by Technology (2023-2030) 6.4.3.2. Germany Transcriptomics Market Size and Forecast, by Product (2023-2030) 6.4.3.3. Germany Transcriptomics Market Size and Forecast, by Application (2023-2030) 6.4.4. Italy 6.4.4.1. Italy Transcriptomics Market Size and Forecast, by Technology (2023-2030) 6.4.4.2. Italy Transcriptomics Market Size and Forecast, by Product (2023-2030) 6.4.4.3. Italy Transcriptomics Market Size and Forecast, by Application (2023-2030) 6.4.5. Spain 6.4.5.1. Spain Transcriptomics Market Size and Forecast, by Technology (2023-2030) 6.4.5.2. Spain Transcriptomics Market Size and Forecast, by Product (2023-2030) 6.4.5.3. Spain Transcriptomics Market Size and Forecast, by Application (2023-2030) 6.4.6. Sweden 6.4.6.1. Sweden Transcriptomics Market Size and Forecast, by Technology (2023-2030) 6.4.6.2. Sweden Transcriptomics Market Size and Forecast, by Product (2023-2030) 6.4.6.3. Sweden Transcriptomics Market Size and Forecast, by Application (2023-2030) 6.4.7. Russia 6.4.7.1. Russia Transcriptomics Market Size and Forecast, by Technology (2023-2030) 6.4.7.2. Russia Transcriptomics Market Size and Forecast, by Product (2023-2030) 6.4.7.3. Russia Transcriptomics Market Size and Forecast, by Application (2023-2030) 6.4.8. Rest of Europe 6.4.8.1. Rest of Europe Transcriptomics Market Size and Forecast, by Technology (2023-2030) 6.4.8.2. Rest of Europe Transcriptomics Market Size and Forecast, by Product (2023-2030) 6.4.8.3. Rest of Europe Transcriptomics Market Size and Forecast, by Application (2023-2030) 7. Asia Pacific Transcriptomics Market Size and Forecast by Segmentation (by Value in USD Mn) (2023-2030) 7.1. Asia Pacific Transcriptomics Market Size and Forecast, by Technology (2023-2030) 7.2. Asia Pacific Transcriptomics Market Size and Forecast, by Product (2023-2030) 7.3. Asia Pacific Transcriptomics Market Size and Forecast, by Application (2023-2030) 7.4. Asia Pacific Transcriptomics Market Size and Forecast, by Industry (2023-2030) 7.5. Asia Pacific Transcriptomics Market Size and Forecast, by Country (2023-2030) 7.5.1. China 7.5.1.1. China Transcriptomics Market Size and Forecast, by Technology (2023-2030) 7.5.1.2. China Transcriptomics Market Size and Forecast, by Product (2023-2030) 7.5.1.3. China Transcriptomics Market Size and Forecast, by Application (2023-2030) 7.5.2. S Korea 7.5.2.1. S Korea Transcriptomics Market Size and Forecast, by Technology (2023-2030) 7.5.2.2. S Korea Transcriptomics Market Size and Forecast, by Product (2023-2030) 7.5.2.3. S Korea Transcriptomics Market Size and Forecast, by Application (2023-2030) 7.5.3. Japan 7.5.3.1. Japan Transcriptomics Market Size and Forecast, by Technology (2023-2030) 7.5.3.2. Japan Transcriptomics Market Size and Forecast, by Product (2023-2030) 7.5.3.3. Japan Transcriptomics Market Size and Forecast, by Application (2023-2030) 7.5.4. India 7.5.4.1. India Transcriptomics Market Size and Forecast, by Technology (2023-2030) 7.5.4.2. India Transcriptomics Market Size and Forecast, by Product (2023-2030) 7.5.4.3. India Transcriptomics Market Size and Forecast, by Application (2023-2030) 7.5.5. Australia 7.5.5.1. Australia Transcriptomics Market Size and Forecast, by Technology (2023-2030) 7.5.5.2. Australia Transcriptomics Market Size and Forecast, by Product (2023-2030) 7.5.5.3. Australia Transcriptomics Market Size and Forecast, by Application (2023-2030) 7.5.6. ASEAN 7.5.6.1. ASEAN Transcriptomics Market Size and Forecast, by Technology (2023-2030) 7.5.6.2. ASEAN Transcriptomics Market Size and Forecast, by Product (2023-2030) 7.5.6.3. ASEAN Transcriptomics Market Size and Forecast, by Application (2023-2030) 7.5.7. Rest of Asia Pacific 7.5.7.1. Rest of Asia Pacific Transcriptomics Market Size and Forecast, by Technology (2023-2030) 7.5.7.2. Rest of Asia Pacific Transcriptomics Market Size and Forecast, by Product (2023-2030) 7.5.7.3. Rest of Asia Pacific Transcriptomics Market Size and Forecast, by Application (2023-2030) 8. Middle East and Africa Transcriptomics Market Size and Forecast by Segmentation (by Value in USD Mn) (2023-2030) 8.1. Middle East and Africa Transcriptomics Market Size and Forecast, by Technology (2023-2030) 8.2. Middle East and Africa Transcriptomics Market Size and Forecast, by Product (2023-2030) 8.3. Middle East and Africa Transcriptomics Market Size and Forecast, by Application (2023-2030) 8.4. Middle East and Africa Transcriptomics Market Size and Forecast, by Country (2023-2030) 8.4.1. South Africa 8.4.1.1. South Africa Transcriptomics Market Size and Forecast, by Technology (2023-2030) 8.4.1.2. South Africa Transcriptomics Market Size and Forecast, by Product (2023-2030) 8.4.1.3. South Africa Transcriptomics Market Size and Forecast, by Application (2023-2030) 8.4.2. GCC 8.4.2.1. GCC Transcriptomics Market Size and Forecast, by Technology (2023-2030) 8.4.2.2. GCC Transcriptomics Market Size and Forecast, by Product (2023-2030) 8.4.2.3. GCC Transcriptomics Market Size and Forecast, by Application (2023-2030) 8.4.3. Rest of ME&A 8.4.3.1. Rest of ME&A Transcriptomics Market Size and Forecast, by Technology (2023-2030) 8.4.3.2. Rest of ME&A Transcriptomics Market Size and Forecast, by Product (2023-2030) 8.4.3.3. Rest of ME&A Transcriptomics Market Size and Forecast, by Application (2023-2030) 9. South America Transcriptomics Market Size and Forecast by Segmentation (by Value in USD Mn) (2023-2030 9.1. South America Transcriptomics Market Size and Forecast, by Technology (2023-2030) 9.2. South America Transcriptomics Market Size and Forecast, by Product (2023-2030) 9.3. South America Transcriptomics Market Size and Forecast, by Application (2023-2030) 9.4. South America Transcriptomics Market Size and Forecast, by Country (2023-2030) 9.4.1. Brazil 9.4.1.1. Brazil Transcriptomics Market Size and Forecast, by Technology (2023-2030) 9.4.1.2. Brazil Transcriptomics Market Size and Forecast, by Product (2023-2030) 9.4.1.3. Brazil Transcriptomics Market Size and Forecast, by Application (2023-2030) 9.4.2. Argentina 9.4.2.1. Argentina Transcriptomics Market Size and Forecast, by Technology (2023-2030) 9.4.2.2. Argentina Transcriptomics Market Size and Forecast, by Product (2023-2030) 9.4.2.3. Argentina Transcriptomics Market Size and Forecast, by Application (2023-2030) 9.4.3. Rest Of South America 9.4.3.1. Rest Of South America Transcriptomics Market Size and Forecast, by Technology (2023-2030) 9.4.3.2. Rest Of South America Transcriptomics Market Size and Forecast, by Product (2023-2030) 9.4.3.3. Rest Of South America Transcriptomics Market Size and Forecast, by Application (2023-2030) 10. Company Profile: Key Players 10.1. Becton 10.1.1. Company Overview 10.1.2. Business Portfolio 10.1.3. Financial Overview 10.1.4. SWOT Analysis 10.1.5. Strategic Analysis 10.1.6. Scale of Operation (small, medium, and large) 10.1.7. Details on Partnership 10.1.8. Regulatory Accreditations and Certifications Received by Them 10.1.9. Awards Received by the Firm 10.1.10. Recent Developments 10.2. GE Healthcare 10.3. Roche Diagnostics 10.4. Agilent Technologies 10.5. Thermo Fisher Scientific 10.6. Illumina, Inc. 10.7. F. Hoffmann-La Roche Ltd 10.8. Beckman Coulter, Inc 10.9. BD 10.10. Biological Industries 10.11. bioMérieux SA 10.12. Bio-Rad Laboratories, Inc 10.13. Cepheid 10.14. Takara Bio Inc. 10.15. Cytognomix 10.16. Edico Genome 10.17. Siemens AG 10.18. QIAGEN 10.19. Merck KGaA 10.20. Kapa Biosystems 10.21. Spatial Transcriptomics 11. Key Findings & Analyst Recommendations 12. Transcriptomics Market: Research Methodology 12.1.1. Top-Down Approach 12.1.2. Bottom-up Approach
